Patents by Inventor Socrates Papapoulos

Socrates Papapoulos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8853187
    Abstract: The present invention relates to a composition for prevention and/or treatment of metabolic diseases of bones comprising at least one bisphosphonate; viscosity agents comprising carboxymethylcellulose and xanthan gum; at least one flavoring agent; and purified water; a process for preparing a composition according to the present invention; and use of such a composition for prevention, treatment and/or diagnosis of metabolic diseases of bones, especially for children.
    Type: Grant
    Filed: June 8, 2009
    Date of Patent: October 7, 2014
    Assignees: Gador S.A., University of Leiden
    Inventors: Daniel Zanetti, Damian Cairatti, Enrique Piccinni, Emilio J. A. Roldan, Socrates Papapoulos
  • Publication number: 20090247491
    Abstract: The present invention relates to a composition for prevention and/or treatment of metabolic diseases of bones comprising at least one bisphosphonate; viscosity agents comprising carboxymethylcellulose and xanthan gum; at least one flavouring agent; and purified water; a process for preparing a composition according to the present invention; and use of such a composition for prevention, treatment and/or diagnosis of metabolic diseases of bones, especially for children.
    Type: Application
    Filed: June 8, 2009
    Publication date: October 1, 2009
    Applicants: Gador S.A., University of Leiden
    Inventors: Daniel Zanetti, Damian Cairatti, Enrique Piccinni, Emilio J.A. Roldan, Socrates Papapoulos
  • Patent number: 7560490
    Abstract: The present invention relates to a composition for prevention and/or treatment of metabolic diseases of bones comprising at least one bisphosphonate; viscosity agents comprising carboxymethylcellulose and xanthan gum; at least one flavoring agent; and purified water; a process for preparing a composition according to the present invention; and use of such a composition for prevention, treatment and/or diagnosis of metabolic diseases of bones, especially for children.
    Type: Grant
    Filed: January 23, 2001
    Date of Patent: July 14, 2009
    Assignees: GADOR S.A., University of Leiden
    Inventors: Daniel Zanetti, Damian Cairatti, Enrique Piccinni, Emilio J. A. Roldan, Socrates Papapoulos
  • Publication number: 20040087550
    Abstract: The present invention relates to a composition for prevention and/or treatment of metabolic diseases of bones comprising at least one bisphosphonate; viscosity agents comprising carboxymethylcellulose and xanthan gum; at least one flavouring agent; and purified water; a process for preparing a composition according to the present invention; and use of such a composition for prevention, treatment and/or diagnosis of metabolic diseases of bones, especially for children.
    Type: Application
    Filed: December 12, 2003
    Publication date: May 6, 2004
    Inventors: Daniel Zanetti, Damian Cairatti, Enrique Piccinni, Emilio J.A. Roldan, Socrates Papapoulos
  • Patent number: 5990098
    Abstract: Use of 1-amino-3-N,N-dimethylamino)-propyliden-1,1-bisphosphonic acid of the structural formula: ##STR1## or of its monosodium or other pharmaceutically acceptable salt, as a biological carrier for bone active substances or for the preparation of a medicament for the diagnosis, prophylaxis and/or treatment of bone and/or mineral metabolism disorders.
    Type: Grant
    Filed: September 1, 1998
    Date of Patent: November 23, 1999
    Assignees: Gador, S.A., University of Leiden
    Inventors: Ermond R. Van Beek, Clemens W. G. M. Lowik, Socrates Papapoulos, Rafael Labriola, Adriana Vecchioli
  • Patent number: 5885973
    Abstract: The present invention provides methods for bone mass anabolic preservation or augmentation in human or other animal subjects affected by osteoporosis or other metabolic bone disorder characterized by systemic or regional bone loss, using bisphosphonates formulations, wherein the bone mass anabolic composition contains effective non-toxic doses of ?3-(N,N-dimethylamine)-1-hydroxypropylidene!-bisphosphonic acid or olpadronate or the monosodium or other pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 10, 1997
    Date of Patent: March 23, 1999
    Assignees: Gador, S.A., University of Leiden
    Inventors: Socrates Papapoulos, Jose Luis Ferretti, Rafael A. Labriola, Nelida Mondelo, Emilio J.A. Roldan